Skip to content

Respiration Rate Monitoring During Transitions

Assessment of Respiration Rate Monitoring During Transitions From Spontaneous to Controlled Ventilation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01881269
Enrollment
27
Registered
2013-06-19
Start date
2013-06-30
Completion date
2013-09-30
Last updated
2013-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus of the Study is Measuring Respiratory Rate

Brief summary

The purpose of this study is to evaluate the performance of the software that calculates respiration rate for the study pulse oximetry monitoring system during transitions of ventilation type from spontaneous breathing to controlled ventilation.

Interventions

None listed

Sponsors

Medtronic - MITG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Be undergoing a procedure with planned general anesthesia involving placement of an endotracheal tube or laryngeal mask airway following induction of anesthesia. * American Society of Anesthesiologists physical status classification (ASA) Status 1, 2 or 3. * Body mass index (BMI) ≤30 kg/m2. * Subject is willing and able to provide written consent.

Exclusion criteria

* Female subjects of child-bearing potential with a positive pregnancy test or an absence of documented non-childbearing status in the medical history records. * Female subjects who are currently lactating and breastfeeding. * Subjects with any evidence of potential difficulty in mask ventilation and/or tracheal intubation. * Subject has an abnormality that may prevent proper application of the device/sensors. * Subject is in atrial fibrillation. * Subject has a documented history of frequent premature ventricular contractions (PVCs), defined as greater than 3 in 30 seconds or greater than 6 in 60 seconds. * Subject has an implanted pacemaker. * Subjects with non-sinus rhythm, frequent premature ventricular complexes (\> 5 min), or abnormal PR, QRS, or QT intervals on screening ECG. * Subjects with artificial finger nails.

Design outcomes

Primary

MeasureTime frameDescription
Time to report a Respiration Rate value after initiation of controlled ventilation1 - 3 minutes after the initiation of controlled ventilationTime (in seconds) for the software to report a Respiration Rate value within one breath per minute of the controlled ventilation rate after placement of the airway device (endotracheal tube or laryngeal mask airway)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026